Pharmaceutical - UK

Filter

Current filters:

UK

Popular Filters

1 to 25 of 339 results

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

24-03-2015

Limited data and the disparate nature of the datasets that are available have been challenges to measuring…

Markets & MarketingNephrology and HepatologyPharmaceuticalSocial IssuesUK

GSK and UK Department of Health in negotiations over Bexsero pricing

GSK and UK Department of Health in negotiations over Bexsero pricing

23-03-2015

UK pharma major GlaxoSmithKline has said it is committed to reaching a conclusion with the UK Department…

BexseroGSKPharmaceuticalPricingUKVaccines

EUSA Pharma launches as an independent business with portfolio and name acquired from Jazz

23-03-2015

EUSA Pharma (EUSA), a newly-established profitable specialty pharmaceutical business headquartered in…

Essex BidcoEUSA PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceuticalUK

Compliance at home and in emerging markets the key challenges to pharma, says study

Compliance at home and in emerging markets the key challenges to pharma, says study

20-03-2015

The UK pharma sector expects one of its biggest challenges to be the risk of incurring fines as they…

Markets & MarketingPharmaceuticalProductionRegulationUK

UK Chancellor’s Budget Statement answers BIA’s calls on both SME access to R&D tax credits

18-03-2015

The UK BioIndustry Association (BIA) welcomes statements made in today’s Budget announced by UK Chancellor…

FinancialPharmaceuticalPoliticsUK

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

17-03-2015

The UK’s Health Secretary Jeremy Hunt has announced a collaborative dementia research initiative between…

Eli LillyGSKJanssenNeurologicalPharmaceuticalResearchUK

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

11-03-2015

Confirming an earlier preliminary guidance, medicines cost watchdog for England, the National Institute…

ArzerraGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationUK

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

11-03-2015

Japanese drug major Eisai has announced that its drug Halaven (eribulin) will remain on the UK's National…

EisaiHalavenOncologyPharmaceuticalRegulationUK

NICE gives go ahead for Xolair to treat potentially disabling skin condition

NICE gives go ahead for Xolair to treat potentially disabling skin condition

11-03-2015

The medicines cost watchdog the National Institute of Health and Care Excellence (NICE) has recommended…

DermatologicalsNovartisPharmaceuticalPricingRegulationUKXolair

Sanofi survey shows oncologists' discomfort with UK Cancer Drugs Fund cuts

Sanofi survey shows oncologists' discomfort with UK Cancer Drugs Fund cuts

10-03-2015

More than three quarters of oncologists agree or strongly agree that cuts to the Cancer Drugs Fund in…

JevtanaOncologyPharmaceuticalSanofiSocial IssuesUK

Scottish Medicines Consortium approves Gilead's Zydelig and B-MS/Pfizer's Eliquis

Scottish Medicines Consortium approves Gilead's Zydelig and B-MS/Pfizer's Eliquis

09-03-2015

The Scottish Medicines Consortium has approved Zydelig (idelalisib) from Gilead for adult chronic lymphocytic…

EliquisGileadHematologyOncologyPharmaceuticalRegulationUKZydelig

ABPI Rheumatology Initiative report says the UK does not prioritize rheumatoid arthritis enough

ABPI Rheumatology Initiative report says the UK does not prioritize rheumatoid arthritis enough

04-03-2015

Rheumatoid arthritis is not given a high enough priority in the UK, according to a new report from the…

Anti-Arthritics/RheumaticsMarkets & MarketingPharmaceuticalResearchSocial IssuesUK

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

BIA welcomes UK’s R&D tax credit scheme

BIA welcomes UK’s R&D tax credit scheme

27-02-2015

The UK BioIndustry Association (BIA) is calling for an extended advance assurance scheme in its response…

FinancialPharmaceuticalUKUK BioIndustry AssociationUnited Kingdom

Chiesi found to have breached ABPI Code

Chiesi found to have breached ABPI Code

27-02-2015

Privately-held Italian drugmaker Chiesi Farmaceutici has been publicly reprimanded for providing inaccurate…

Chiesi FarmaceuticiFostairLegalPharmaceuticalRegulationUK

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

26-02-2015

Jim O'Neill, chair of the UK government's review on antimicrobial resistance (AMR), spoke of the need…

AMRAntibiotics and Infectious diseasesPharma SummitPharmaceuticalUK

NICE recommends Sovaldi and Olysio for hepatitis C

NICE recommends Sovaldi and Olysio for hepatitis C

25-02-2015

The UK’s National Institute for Health and Care Excellence (NICE) has published final guidance recommending…

Anti-viralsGilead SciencesJanssenOlysioPharmaceuticalRegulationSovaldiUK

NICE recommends AbbVie's Humira and Merck's Remicade and Simponi for ulcerative colitis

NICE recommends AbbVie's Humira and Merck's Remicade and Simponi for ulcerative colitis

25-02-2015

The UK’s health regulator, the National Institute for Health and Care Excellence (NICE) has recommended…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalRegulationRemicadeSimponi InjectionUK

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Takeda links with a London university to develop novel gastroenterology products

Takeda links with a London university to develop novel gastroenterology products

22-02-2015

The UK’s Queen Mary University of London (QMUL) and Takeda Pharmaceutical, Japan’s largest drugmaker,…

Gastro-intestinalsPharmaceuticalResearchTakeda PharmaceuticalUKUniversity of London

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

20-02-2015

The UK’s National Institutes of Health and Care Excellence has recommended Ozurdex (dexamethasone),…

AllerganDexamethasoneOphthalmicsOzurdexPharmaceuticalRegulationUK

1 to 25 of 339 results

Back to top